Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

L. Ratner; D. Rauch; H. Abel; B. Caruso; A. Noy; S. K. Barta; S. Parekh; J. C. Ramos; R. Ambinder; A. Phillips; J. Harding; H. H. Baydoun; X. Cheng; S. Jacobson

doi:10.1038/BCJ.2016.21

Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

L. Ratner, D. Rauch, H. Abel, B. Caruso, A. Noy, S. K. Barta, S. Parekh, J. C. Ramos, R. Ambinder, A. Phillips, J. Harding, H. H. Baydoun, X. Cheng, S. Jacobson

Research output: Contribution to journal › Letter › peer-review

30 Scopus citations

Original language	English
Article number	e408
Journal	Blood cancer journal
Volume	6
Issue number	3
DOIs	https://doi.org/10.1038/BCJ.2016.21
State	Published - Mar 2016

Access to Document

10.1038/BCJ.2016.21

Cite this

Ratner, L., Rauch, D., Abel, H., Caruso, B., Noy, A., Barta, S. K., Parekh, S., Ramos, J. C., Ambinder, R., Phillips, A., Harding, J., Baydoun, H. H., Cheng, X., & Jacobson, S. (2016). Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma. Blood cancer journal, 6(3), Article e408. https://doi.org/10.1038/BCJ.2016.21

@article{c21d6e419f274067979d814fc413da67,

title = "Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma",

author = "L. Ratner and D. Rauch and H. Abel and B. Caruso and A. Noy and Barta, {S. K.} and S. Parekh and Ramos, {J. C.} and R. Ambinder and A. Phillips and J. Harding and Baydoun, {H. H.} and X. Cheng and S. Jacobson",

year = "2016",

month = mar,

doi = "10.1038/BCJ.2016.21",

language = "English",

volume = "6",

journal = "Blood cancer journal",

issn = "2044-5385",

number = "3",

}

Ratner, L , Rauch, D, Abel, H, Caruso, B, Noy, A, Barta, SK, Parekh, S, Ramos, JC, Ambinder, R, Phillips, A, Harding, J, Baydoun, HH, Cheng, X & Jacobson, S 2016, 'Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma', Blood cancer journal, vol. 6, no. 3, e408. https://doi.org/10.1038/BCJ.2016.21

TY - JOUR

T1 - Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

AU - Ratner, L.

AU - Rauch, D.

AU - Abel, H.

AU - Caruso, B.

AU - Noy, A.

AU - Barta, S. K.

AU - Parekh, S.

AU - Ramos, J. C.

AU - Ambinder, R.

AU - Phillips, A.

AU - Harding, J.

AU - Baydoun, H. H.

AU - Cheng, X.

AU - Jacobson, S.

PY - 2016/3

Y1 - 2016/3

UR - http://www.scopus.com/inward/record.url?scp=85013692945&partnerID=8YFLogxK

U2 - 10.1038/BCJ.2016.21

DO - 10.1038/BCJ.2016.21

M3 - Letter

C2 - 27015285

AN - SCOPUS:85013692945

SN - 2044-5385

VL - 6

JO - Blood cancer journal

JF - Blood cancer journal

IS - 3

M1 - e408

ER -

Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

Access to Document

Other files and links

Cite this